Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus.
Jyh-Ming LiouPeter MalfertheinerYi-Chia LeeBor-Shyang SheuKentaro SuganoHsiu-Chi ChengKhay-Guan YeohPing-I HsuKhean-Lee GohVarocha MahachaiTakuji GotodaWei-Lun ChangMei-Jyh ChenTsung-Hsien ChiangChieh-Chang ChenChun-Ying WuAlex Hwong-Ruey LeowJeng-Yih WuDeng-Chyang WuTzu-Chan HongHong LuAri Fahrial SyamFrancis MegraudFrancis Ka Leung ChanJoseph Jy SungJaw-Town LinDavid Yates GrahamMing-Shiang WuEmad M El-Omarnull nullPublished in: Gut (2020)
Evidence supports the proposal that eradication therapy should be offered to all individuals infected with H. pylori. Vulnerable subjects should be tested, and treated if the test is positive. Mass screening and eradication of H. pylori should be considered in populations at higher risk of GC.